International Association for the Study of Lung Cancer posted on LinkedIn:
“The creativity of the IASLC 2026 Targeted Therapies of Lung Cancer faculty never disappoints.
Catherine Shu from Columbia University Irving Medical Center Human Resources presented “Treatment Landscape for EGFR Ex20 Mutations” opening with a slide that aligned the timeline of EGFR Exon 20 discoveries with Taylor Swift’s career.
It was a powerful reminder that many of these discoveries are remarkably recent and how much progress has been made in a relatively short time.
Reminder: TTLC26 content will be available free to IASLC members 48 hours after the conference on Lung Cancer 360.”
Other articles about Lung Cancer on OncoDaily.